Accordingly, EMT‐regulating genes, such as Snail1 [Rowe et al., 2011] and HNF4α [Yue et al., 2010], have been emerging as targets as part of a new concept for treating liver fibrosis. This evidence concerns the gene HNF4A and Hepatic fibrosis.